Introvale Kit
Product Images NDC 70700-117

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Introvale (NDC 70700-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Introvale Blister Label

Medication calendar diagram for Introvale, a kit format containing a 13-week supply with 91 tablets. The diagram shows a weekly layout with circular tablet placeholders labeled by day of the week (Sunday to Saturday) and week number (Week 1 to Week 13). Arrows indicate the sequence of tablet intake beginning at Week 1 and continuing through Week 13, with storage instructions noted below the diagram.*

FDA Label Image

Introvale Carton Label

Introvale 0.15 mg/0.03 mg kit packaging label for Levonorgestrel and Ethinyl Estradiol tablets, USP. The label states a 91-day regimen with 91 tablets per unit. It features instructions for usual dosage, storage temperature, and notes that it is Rx only. Manufactured by Laboratorios León Farma S.A. for Xiromed, LLC in Florida Park, NJ, USA. The label is primarily yellow and white with Xiromed branding and includes barcodes and identifying numbers.*

FDA Label Image

Introvale Chemical Structure 1

Chemical structure diagram of an active pharmaceutical ingredient shown in the product data, likely Levonorgestrel or Ethinyl Estradiol, depicting interconnected hexagonal and pentagonal rings with attached functional groups.*

FDA Label Image

Introvale Chemical Structure 2

Chemical structure diagram of Levonorgestrel, one of the active ingredients in Introvale, showing the molecular arrangement with labeled hydroxyl and methyl groups.*

FDA Label Image

Introvale Figure 1

A vertical arrow chart showing the effectiveness of various birth control methods ranked by the number of pregnancies per 100 women in one year. At the top, labeled 'Fewer Pregnancies,' are implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones. Mid-range methods include condoms and diaphragm. Lower effectiveness methods, toward 'More Pregnancies,' include no sex during fertile days, spermicide, withdrawal, and no birth control at the bottom.*

FDA Label Image

Introvale Figure 2

A forest plot chart presenting effect estimates comparing ever use and current use of combined oral contraceptives (COC) versus never use. The chart includes study names, years, and statistical values such as Odds Ratios (OR), Relative Risks (RR), and Hazard Ratios (HR) with confidence intervals. The horizontal axis is labeled 'Effect Estimate' ranging approximately from -1.50 to 2.00.*

FDA Label Image

Introvale Figure 3

Illustration showing a weekly pill schedule for the Introvale kit. The diagram displays four rows of circular pill icons labeled by day of the week from Sunday to Saturday, with arrows indicating the order to take each pill across the weeks (Week 1 to Week 4). A hand points to the starting pill on Sunday, marking the beginning of the regimen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.